Bavituximab, also TRWH-783, represents an exciting immunotherapy approach targeting phosphatidylserine (PS). PS is usually a cellular lipid found on cell membranes; however, it's commonly shown on the outer of tumor https://bookmark-dofollow.com/story28129043/bavituximab-a-new-strategy-to-malignant-management